Skip to main content
SpringerLink
Log in

Pelvic inflammatory disease

Current concepts and treatment guidelines

  • Clinical Reviews
  • Published:
Journal of General Internal Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Westrom L. Incidence, prevalence and trends of acute pelvic inflammatory disease and its consequences in industrialized countries. Am J Obstet Gynecol 1980;138:880–92

    Article  CAS  PubMed  Google Scholar 

  2. Washington AE, Cates W Jr, Zaidi AA. Hospitalizations for pelvic inflammatory disease: epidemiology and trends in the United States, 1975 to 1981. JAMA 1984;251:2529–33

    Article  CAS  PubMed  Google Scholar 

  3. Blount JH, Reynolds GH, Rice RJ. Pelvic inflammatory disease: incidence and trends in private practice. MMWR CDC Surveill Summ 1983;32:27SS-34SS

    CAS  PubMed  Google Scholar 

  4. Washington AE, Arno PS, Brooks MA. The economic cost of pelvic inflammatory disease. JAMA 1986;255:1735–8

    Article  CAS  PubMed  Google Scholar 

  5. Helvancioglu A, Long EM Jr, Yang S-L. Ectopic pregnancy: an eight-year review. J Reprod Med 1979;22:87–92

    Google Scholar 

  6. Center for Disease Control. Ectopic pregnancies — United States, 1981–1983. MMWR 1986;35:289–91

    Google Scholar 

  7. Final monthly vital statistics report. Maternal deaths, 1977; final mortality statistics, 1977, National Center for Health Statistics, HEW Pub. No. (PHS) 79-1120, vol. 27, no. 1, suppl., May 11, 1979

  8. Curran JW. Economic consequences of pelvic inflammatory disease in the United States. Am J Obstet Gynecol 1980;138:848–51

    Article  CAS  PubMed  Google Scholar 

  9. Westrom L. Effect of acute pelvic inflammatory disease on fertility. Am J Obstet Gynecol 1975;121:707–13

    Article  CAS  PubMed  Google Scholar 

  10. Gump DW, Gibson M, Ashikaga T. Evidence of prior pelvic inflammatory disease and its relationship toChlamydia trachomatis antibody and intrauterine contraceptive device use in infertile women. Am J Obstet Gynecol 1983;146:153–9

    Article  CAS  PubMed  Google Scholar 

  11. Landers DV, Sweet RL. Tubo-ovarian abscess: contemporary approach to management. Rev Infect Dis 1983;5:876–84

    Article  CAS  PubMed  Google Scholar 

  12. Ginsburg DS, Stern JL, Hamod KA, Genadry R, Spence MR. Tubo-ovarian abscess: a retrospective review. Am J Obstet Gynecol 1980;138:1055–8

    Article  CAS  PubMed  Google Scholar 

  13. Eschenbach DA. New concepts of obstetric and gynecologic infection. Arch Intern Med 1982;142:2039–44

    Article  CAS  PubMed  Google Scholar 

  14. Mascola L, Albritton WL, Cates W, Reynolds GH, Blount JH. Gonorrhea and salpingitis among American teenagers, 1960–1981. MMWR 1983;32:25SS-30SS

    CAS  PubMed  Google Scholar 

  15. Platt R, Rice PA, McCormack WM. Risk of acquiring gonorrhea and prevalence of abnormal adnexal findings among women recently exposed to gonorrhea. JAMA 1983;250:3205–9

    Article  CAS  PubMed  Google Scholar 

  16. Penicillinase-producingNeisseria gonorrhoeae — United States, Florida. MMWR 1986;35:12–4

  17. Jaffe HW, Biddle JW, Johnson SR, et al. Infections due to penicillinase-producingNeisseria gonorrhoeae in the United States: 1976–1980. J Infect Dis 1981;144:191–7

    Article  CAS  PubMed  Google Scholar 

  18. Faruki H, Kohmescher RN, McKinney P, Sparling PF. A community-based outbreak of infection with penicillin-resistantNeisseria gonorrhoeae not producing penicillinase (chromosomally mediated resistance). N Engl J Med 1985;313:607–11

    Article  CAS  PubMed  Google Scholar 

  19. Rice RJ, Biddle JW, JeanLouis YA, Dewitt WE, Blount JH, Morse SA. Chromosomally mediated resistance inNeisseria gonorrhoeae in the United States: results of surveillance and reporting, 1983–1984. J Infect Dis 1986;153:340–5

    Article  CAS  PubMed  Google Scholar 

  20. Centers for Disease Control.Chlamydia trachomatis infections: policy guidelines for prevention and control. MMWR 1985;34(suppl 3S):53S-74S

    Google Scholar 

  21. McCormack WM, Rosner B, McComb DE, et al. Infection withChlamydia trachomatis in female college students. Am J Epidemiol 1985;121:107–15

    Article  CAS  PubMed  Google Scholar 

  22. Chernesky MA, Mahoney JB, Castriciano S, et al. Detection ofChlamydia trachomatis antigens by enzyme immunoassay and immunofluorescence in genital specimens from symptomatic and asymptomatic men and women. J Infect Dis 1986;154:141–8

    Article  CAS  PubMed  Google Scholar 

  23. Brunham RC, Maclean IW, Binns B, Peeling RW.Chlamydia trachomatis: its role in tubal infertility. J Infect Dis 1985;152:1275–82

    Article  CAS  PubMed  Google Scholar 

  24. Henry-Suchet J, Catalan F, Loffredo V, et al. Microbiology of specimens obtained by laparoscopy from controls and from patients with pelvic inflammatory disease or infertility with tubal obstruction:Chlamydia trachomatis andUrea-plasma urealyticum. Am J Obstet Gynecol 1980;138:1022–5

    Article  CAS  PubMed  Google Scholar 

  25. Sweet RL, Mills J, Hadley KW, et al. Use of laparoscopy to determine the microbiologic etiology of acute salpingitis. Am J Obstet Gynecol 1979;134:68–74

    Article  CAS  PubMed  Google Scholar 

  26. Holmes KK. Lower genital tract infections in women: cystitis/urethritis, vulvovaginitis, and cervicitis. In: Holmes KK, Mardh P-A, Sparling PF, Weisner PJ, eds. Sexually transmitted diseases. New York: McGraw-Hill, 1984;557–89

    Google Scholar 

  27. Cunningham FG, Hauth JC, Gilstrap LC, Herbert WNP, Kappus SS. The bacterial pathogenesis of acute pelvic inflammatory disease. Obstet Gynecol 1978;52:161–4

    CAS  PubMed  Google Scholar 

  28. Lee NC, Rubin GL, Ory HW, Burkman RT. Type of intrauterine device and the risk of pelvic inflammatory disease. Obstet Gynecol 1983;62:1–6

    CAS  PubMed  Google Scholar 

  29. Flesh G, Weiner JM, Corlett RC, et al. The intrauterine contraceptive device and acute salpingitis: a multifactor analysis. Am J Obstet Gynecol 1979;135:402–8

    Article  CAS  PubMed  Google Scholar 

  30. Burkman RT, and the Women’s Health Study. Association between intrauterine device and pelvic inflammatory disease. Obstet Gynecol 1981;57:269–76

    CAS  PubMed  Google Scholar 

  31. Sweet RL, Blankfort-Doyle M, Robbie MO, Schacter J. The occurrence of chlamydial and gonococcal salpingitis during the menstrual cycle. JAMA 1986;255:2062–4

    Article  CAS  PubMed  Google Scholar 

  32. Kalaghan J, Rubin GL, Ory HW, et al. Barrier-method contraceptives and pelvic inflammatory disease. JAMA 1982;248:184–7

    Article  Google Scholar 

  33. Cramer DW, Schiff I, Schoenbaum SC, et al. Tubal infertility and the intrauterine device. N Engl J Med 1985;312:941–7

    Article  CAS  PubMed  Google Scholar 

  34. Daling JR, Weiss NS, Metch BJ, et al. Primary tubal infertility in relation to the use of an intrauterine device. N Engl J Med 1985;312:937–41

    Article  CAS  PubMed  Google Scholar 

  35. Eschenbach DA, Harnisch JP, Holmes KK. Pathogenesis of acute pelvic inflammatory disease: role of contraception and other risk factors. Am J Obstet Gynecol 1977;128:838–50

    Article  CAS  PubMed  Google Scholar 

  36. Washington AE, Gove S, Schacter J, Sweet RL. Oral contraceptives,Chlamydia trachomatis infections and pelvic inflammatory disease. A word of caution about protection. JAMA 1985;253:2246–50

    Article  CAS  PubMed  Google Scholar 

  37. Jacobson L, Westrom L. Objectivized diagnosis of acute pelvic inflammatory disease: diagnostic and prognostic value of routine laparoscopy. Am J Obstet Gynecol 1969;105:1088–98

    Article  CAS  PubMed  Google Scholar 

  38. Chaparro MV, Ghosh S, Nashed A, Poliak A. Laparoscopy for the confirmation and prognostic evaluation of pelvic inflammatory disease. Int J Gynecol Obstet 1978;15:307–9

    Article  CAS  Google Scholar 

  39. Sweet RL, Draper DL, Schachter J, James J, Hadley WK, Brooks GF. Microbiology and pathogenesis of acute salpingitis as determined by laparoscopy: what is the appropriate site to sample? Am J Obstet Gynecol 1980;138:985–9

    Article  CAS  PubMed  Google Scholar 

  40. Wasserheit JN, Bell TA, Kiviat NB, et al. Microbial causes of proven pelvic inflammatory disease and efficacy of clindamycin and tobramycin. Ann Intern Med 1986;104:187–93

    Article  CAS  PubMed  Google Scholar 

  41. Tam MR, Stamm WE, Handsfield H, et al. Culture-independent diagnosis ofChlamydia trachomatis using monoclonal antibodies. N Engl J Med 1984;310:1146–50

    Article  CAS  PubMed  Google Scholar 

  42. Dowda HE, Parker EK, Redden SE, et al. Evaluation of the chlamydiazyme EIA for the detection ofChlamydia trachomatis in genital specimens (abstr #54). Interscience Conference on Antimicrobial Agents and Chemotherapy Proceedings, Oct 24–26, 1983:88

  43. Svensson L, Westrom L, Ripa KT, et al. Differences in some clinical and laboratory parameters in acute salpingitis related to culture and serologic findings. Am J Obstet Gynecol 1980;138:1017–21

    Article  CAS  PubMed  Google Scholar 

  44. Centers for Disease Control. 1985 STD treatment guidelines. MMWR 1985;34(suppl 4S):92S-94S

    Google Scholar 

  45. Brunham RC. Therapy for acute pelvic inflammatory disease: a critique of recent treatment trials. Am J Obstet Gynecol 1984;148:235–40

    Article  CAS  PubMed  Google Scholar 

  46. Ridgway GL, Owen JM, Oriel JD. The antimicrobial susceptibility ofChlamydia trachomatis in cell culture. Br J Vener Dis 1978;54:103–6

    CAS  PubMed  PubMed Central  Google Scholar 

  47. Stamm WE, Guinam ME, Johnson C, Starcher T, Holmes KK, McCormack WM. Effect of treatment regimens forNeisseria gonorrhoeae on simultaneous infection withChlamydia trachomatis. N Engl J Med 1984;310:545–9

    Article  CAS  PubMed  Google Scholar 

  48. Rees E. The treatment of pelvic inflammatory disease. Am J Obstet Gynecol 1980;138:1042–7

    Article  CAS  PubMed  Google Scholar 

  49. Bieluch VM, Tally FP. Pathophysiology of abscess formation. Clin Obstet Gynecol 1983;10:93–103

    CAS  Google Scholar 

  50. Edson RS, Rosenblatt JE, Lee DT, McVey EA III. Recent experience with antimicrobial susceptibility of anaerobic bacteria: increasing resistance to penicillin. Mayo Clin Proc 1982;57:737–41

    CAS  PubMed  Google Scholar 

  51. Cunningham FG, Hauth JC, Strong JD, et al: Evaluation of tetracycline or penicillin and ampicillin for treatment of acute pelvic inflammatory disease. N Engl J Med 1977;296:1380–3

    Article  CAS  PubMed  Google Scholar 

  52. Wright AJ, Wilkowski CJ. The penicillins. Mayo Clin Proc 1983;58:21–32

    CAS  PubMed  Google Scholar 

  53. Sanders CV, Greenberg RN, Marier R. Cefamandole and cefoxitin. Ann Intern Med 1985;103:70–8

    Article  CAS  PubMed  Google Scholar 

  54. LeFrock JL, Molavi A, Carr B, et al. Comparative clinical evaluation of mezlocillin and cefoxitin. J Antimicrob Chemother 1982;9(suppl A):199–203

    Article  PubMed  Google Scholar 

  55. Sweet RL, Robbie MO, Ohm-Smith M, Hadley WK. Comparative study of piperacillin versus cefoxitin in the treatment of obstetric and gynecologic infections. Am J Obstet Gynecol 1983;145:342–9

    Article  CAS  PubMed  Google Scholar 

  56. Sweet RL, Schachter J, Robbie MO. Failure of B-lactam antibiotics to eradicateChlamydia trachomatis in the endometrium despite apparent clinical cure of acute salpingitis. JAMA 1983;250:2641–5

    Article  CAS  PubMed  Google Scholar 

  57. Thompson SE, Dretler RH. Epidemiology and treatment of chlamydial infections in pregnant women and infants. Rev Infect Dis 1982;4:747–57

    Article  Google Scholar 

  58. Sweet RL, Schachter J, Ohm-Smith M, et al. Treatment of acute PID: cefoxitin plus doxycycline versus clindamycin plus tobramycin [abstr #271]. Interscience Conference on Antimicrobial Agents and Chemotherapy Proceedings, Sept 29–Oct 2, 1985;140

  59. Dodson MG, Faro S. The polymicrobial etiology of acute pelvic inflammatory disease and treatment regimens. Rev Infect Dis 1985;7(4):S696-S702

    Article  PubMed  Google Scholar 

  60. Sexually transmitted disease treatment guidelines — 1982. MMWR 31:4S, 1982

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Division of Infectious Diseases, Boston City Hospital, 774 Albany St., 02118, Boston, MA

    Peter A. Dale MD, Peter A. Rice MD & Kenneth C. Edelin MD

Authors
  1. Peter A. Dale MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Peter A. Rice MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kenneth C. Edelin MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Received from Boston University School of Medicine and Boston City Hospital, Boston, Massachusetts.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dale, P.A., Rice, P.A. & Edelin, K.C. Pelvic inflammatory disease. J Gen Intern Med 1, 412–417 (1986). https://doi.org/10.1007/BF02596429

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02596429

Keywords

Search

Navigation